Well, as you've probably guessed, the weekend was an absolute blast. And not only that, around the time I started to wake up again I got some startlingly excellent news. Celera Genomics (as was) has decided to admit that they can't make a living selling their version of the genome. Slashdot's take on this (which is mainly people's comments rather than in itself being terribly informative) is
here. It does, however, link to a Business Week story
here and a New York Times story (free registration required)
here.
They are publishing their data freely on the usual public databases once existing subscriptions run out.
Now, in a sense this is now fairly irrelevant, but as I spent a couple of years trying, with a small army of other people, to spike their business plan, I find it hard not to take a continuing personal interest.
All opinions expressed after this point are those of the author and are not necessarily factual. This is how I remember it, and while I have a fairly good memory it's not infallible. All points should be readily (dis)provable by someone with a few minutes to spare, though.
( Overly long, badly written and probably not of any remaining interest to anyone not at least slightly obsessive. Possibly also a little technical at points. )